RAJ, R.; KUMAR, A.; PRACHI SOOD; KUMAR, R.; RANA, V. Randomized Phase III Trial Comparing Epirubicin/ Doxorubicin Plus Docetaxel and Epirubicin/ Doxorubicin Plus Paclitaxel as First Line Treatment in Women with Advanced Breast Cancer. Journal for Research in Applied Sciences and Biotechnology, [S. l.], v. 2, n. 3, p. 55–63, 2023. DOI: 10.55544/jrasb.2.3.8. Disponível em: https://jrasb.com/index.php/jrasb/article/view/232. Acesso em: 24 nov. 2024.